Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Dasatinib
Sponsor: Baylor Breast Care Center
Collaborators: M.D. Anderson Cancer Center